AU2001277938A1 - Method for treating angina - Google Patents

Method for treating angina

Info

Publication number
AU2001277938A1
AU2001277938A1 AU2001277938A AU7793801A AU2001277938A1 AU 2001277938 A1 AU2001277938 A1 AU 2001277938A1 AU 2001277938 A AU2001277938 A AU 2001277938A AU 7793801 A AU7793801 A AU 7793801A AU 2001277938 A1 AU2001277938 A1 AU 2001277938A1
Authority
AU
Australia
Prior art keywords
treating angina
angina
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277938A
Inventor
Brent K. Blackburn
Andrew A. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Palo Alto Inc
Original Assignee
CV Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Therapeutics Inc filed Critical CV Therapeutics Inc
Publication of AU2001277938A1 publication Critical patent/AU2001277938A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2001277938A 2000-07-21 2001-07-20 Method for treating angina Abandoned AU2001277938A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22012600P 2000-07-21 2000-07-21
US60220126 2000-07-21
PCT/US2001/022957 WO2002007716A2 (en) 2000-07-21 2001-07-20 Method for treating angina

Publications (1)

Publication Number Publication Date
AU2001277938A1 true AU2001277938A1 (en) 2002-02-05

Family

ID=22822174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277938A Abandoned AU2001277938A1 (en) 2000-07-21 2001-07-20 Method for treating angina

Country Status (3)

Country Link
US (1) US20020052377A1 (en)
AU (1) AU2001277938A1 (en)
WO (1) WO2002007716A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220344A1 (en) * 2002-04-04 2003-11-27 Luiz Belardinelli Method of treating arrhythmias
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
EP1505977B1 (en) * 2002-05-21 2014-09-10 Gilead Sciences, Inc. Administration of a partial fatty acid oxidation inhibitor such as ranolazine for the treatment of diabetes
JP2008519770A (en) * 2004-11-09 2008-06-12 シーブイ・セラピューティクス・インコーポレイテッド Use of ranolazine in combination with at least one remodeling agent to reverse left ventricular remodeling in the treatment of heart failure
JP2010518181A (en) * 2007-02-13 2010-05-27 ギリアード・パロ・アルト・インコーポレイテッド Use of ranolazine for the treatment of cardiovascular disease
CA2678325A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of non-coronary microvascular diseases
US20090111826A1 (en) * 2007-02-13 2009-04-30 Louis Lange Use of ranolazine for the treatment of cardiovascular diseases
WO2008101008A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of coronary microvascular diseases
US20080233191A1 (en) * 2007-03-22 2008-09-25 Brent Blackburn Use of ranolazine for elevated brain-type natriuretic peptide
KR20100015685A (en) * 2007-04-12 2010-02-12 씨브이 쎄러퓨틱스, 인코포레이티드 Ranolazine for enhancing insulin secretion
EA200971073A1 (en) * 2007-05-31 2010-08-30 Джилид Пало Альто, Инк. APPLICATION OF RANOLAZINE AT AN INCREASED LEVEL OF NATURAURETIC PEPTIDE OF THE BRAIN TYPE
CA2761771A1 (en) * 2009-05-14 2010-11-18 Gilead Sciences, Inc. Ranolazine for the treatment of cns disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
US6303607B1 (en) * 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation

Also Published As

Publication number Publication date
WO2002007716A3 (en) 2002-06-06
US20020052377A1 (en) 2002-05-02
WO2002007716A2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
WO2002030487A8 (en) Methods for treating aneurysms
AU2002324574A1 (en) Methods for treating prostatitis
AU2651701A (en) Method for introducing additives
AU2001238369A1 (en) Method for treating thyroid disorders
AU2001231104A1 (en) Methods for treating diabetes
AU2002215125A1 (en) Well treatment method
AU2002210881A1 (en) Transdermal method
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU3222801A (en) Method for treating oil-containing sludge
AU2001277938A1 (en) Method for treating angina
AUPR152100A0 (en) Method for treating coral
AU2001267978A1 (en) Method for analyzing words
AU2001233699A1 (en) Method for selecting products
AU2001287822A1 (en) Method for tensioning multiple-strand cables
AU2001276005A1 (en) Method for treating a neoplasm
AU2002241670A1 (en) Method for treating glaucoma IB
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001282004A1 (en) Method for treating unstable angina pectoris
AU5650401A (en) Method for enhancing cognitive function
HUP0300730A3 (en) Method for treating unstable angina pectoris
AU2001237530A1 (en) Method
AU2001248372A1 (en) Method for executing access control
AU2001241636A1 (en) Halotherapy method
AU2001230253A1 (en) Processing method
AU2001243297A1 (en) Method for treating or preventing depression